CN1181980A - 来自氧化多糖类的可生物吸收的医用品 - Google Patents
来自氧化多糖类的可生物吸收的医用品 Download PDFInfo
- Publication number
- CN1181980A CN1181980A CN97117113.0A CN97117113A CN1181980A CN 1181980 A CN1181980 A CN 1181980A CN 97117113 A CN97117113 A CN 97117113A CN 1181980 A CN1181980 A CN 1181980A
- Authority
- CN
- China
- Prior art keywords
- cellulose
- oxidation
- adhesion
- water
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 title claims description 13
- 229920001282 polysaccharide Polymers 0.000 title claims description 13
- 239000005017 polysaccharide Substances 0.000 title claims description 13
- 239000000463 material Substances 0.000 claims abstract description 87
- 229920000609 methyl cellulose Polymers 0.000 claims abstract description 76
- 235000010981 methylcellulose Nutrition 0.000 claims abstract description 76
- 239000001923 methylcellulose Substances 0.000 claims abstract description 72
- 229920002678 cellulose Polymers 0.000 claims abstract description 49
- 239000001913 cellulose Substances 0.000 claims abstract description 49
- 235000010980 cellulose Nutrition 0.000 claims abstract description 49
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 46
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 42
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 42
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000499 gel Substances 0.000 claims abstract description 29
- 229920002301 cellulose acetate Polymers 0.000 claims abstract description 14
- 230000001590 oxidative effect Effects 0.000 claims abstract description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 6
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 6
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 6
- 230000003647 oxidation Effects 0.000 claims description 110
- 238000007254 oxidation reaction Methods 0.000 claims description 110
- 238000000034 method Methods 0.000 claims description 63
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 59
- 239000000243 solution Substances 0.000 claims description 55
- 239000004744 fabric Substances 0.000 claims description 36
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 claims description 30
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 30
- 238000002360 preparation method Methods 0.000 claims description 20
- 238000006467 substitution reaction Methods 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 229920002201 Oxidized cellulose Polymers 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 229940107304 oxidized cellulose Drugs 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000007800 oxidant agent Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 9
- WFPZPJSADLPSON-UHFFFAOYSA-N dinitrogen tetraoxide Chemical compound [O-][N+](=O)[N+]([O-])=O WFPZPJSADLPSON-UHFFFAOYSA-N 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 239000001856 Ethyl cellulose Substances 0.000 claims description 6
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 6
- 229920001249 ethyl cellulose Polymers 0.000 claims description 6
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 6
- 210000000115 thoracic cavity Anatomy 0.000 claims description 6
- 229920001503 Glucan Polymers 0.000 claims description 4
- 239000000017 hydrogel Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920002752 Konjac Polymers 0.000 claims description 2
- 229920002732 Polyanhydride Polymers 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000000252 konjac Substances 0.000 claims description 2
- 235000010485 konjac Nutrition 0.000 claims description 2
- 210000004197 pelvis Anatomy 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims 2
- 102000016942 Elastin Human genes 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 238000006735 epoxidation reaction Methods 0.000 claims 1
- 210000003128 head Anatomy 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 210000004303 peritoneum Anatomy 0.000 claims 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 239000004632 polycaprolactone Substances 0.000 claims 1
- 239000000622 polydioxanone Substances 0.000 claims 1
- 229940032147 starch Drugs 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
- 208000031737 Tissue Adhesions Diseases 0.000 abstract description 10
- 229940081735 acetylcellulose Drugs 0.000 abstract description 10
- 230000023597 hemostasis Effects 0.000 abstract description 4
- ZAMLGGRVTAXBHI-UHFFFAOYSA-N 3-(4-bromophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(CC(O)=O)C1=CC=C(Br)C=C1 ZAMLGGRVTAXBHI-UHFFFAOYSA-N 0.000 abstract 1
- 239000010408 film Substances 0.000 description 46
- 229920000642 polymer Polymers 0.000 description 32
- 239000011347 resin Substances 0.000 description 30
- 229920005989 resin Polymers 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 20
- 239000000843 powder Substances 0.000 description 19
- 210000004379 membrane Anatomy 0.000 description 18
- 239000012528 membrane Substances 0.000 description 18
- 208000027418 Wounds and injury Diseases 0.000 description 17
- 206010052428 Wound Diseases 0.000 description 16
- 239000003814 drug Substances 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 14
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000835 fiber Substances 0.000 description 13
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- 208000032843 Hemorrhage Diseases 0.000 description 12
- IWLUJCZGMDWKRT-UHFFFAOYSA-N azane oxygen(2-) titanium(4+) Chemical compound N.[O-2].[Ti+4].[O-2] IWLUJCZGMDWKRT-UHFFFAOYSA-N 0.000 description 12
- 229920000669 heparin Polymers 0.000 description 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 11
- 230000004888 barrier function Effects 0.000 description 11
- 229960002897 heparin Drugs 0.000 description 11
- 210000004291 uterus Anatomy 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241001597008 Nomeidae Species 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000002980 postoperative effect Effects 0.000 description 6
- 239000004627 regenerated cellulose Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000003187 abdominal effect Effects 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940127554 medical product Drugs 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 238000004448 titration Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 229920013683 Celanese Polymers 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- 229920003091 Methocel™ Polymers 0.000 description 3
- 229920003108 Methocel™ A4M Polymers 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000003518 caustics Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000010224 hepatic metabolism Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 210000001562 sternum Anatomy 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- AJDIZQLSFPQPEY-UHFFFAOYSA-N 1,1,2-Trichlorotrifluoroethane Chemical compound FC(F)(Cl)C(F)(Cl)Cl AJDIZQLSFPQPEY-UHFFFAOYSA-N 0.000 description 2
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 2
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 229920003105 Methocel™ A15 LV Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- -1 carboxylate radical Chemical class 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002682 general surgery Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 102200006535 rs104894361 Human genes 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000007631 vascular surgery Methods 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 241000819038 Chichester Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 206010022945 Iris adhesions Diseases 0.000 description 1
- VGGLHLAESQEWCR-UHFFFAOYSA-N N-(hydroxymethyl)urea Chemical compound NC(=O)NCO VGGLHLAESQEWCR-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034650 Peritoneal adhesions Diseases 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 125000003198 secondary alcohol group Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 210000004231 tunica media Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940035658 visco-gel Drugs 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2075896P | 1996-06-28 | 1996-06-28 | |
| US020,758 | 1996-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1181980A true CN1181980A (zh) | 1998-05-20 |
Family
ID=21800405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97117113.0A Pending CN1181980A (zh) | 1996-06-28 | 1997-06-28 | 来自氧化多糖类的可生物吸收的医用品 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0815879B1 (enExample) |
| JP (1) | JPH1066723A (enExample) |
| CN (1) | CN1181980A (enExample) |
| AU (1) | AU725479B2 (enExample) |
| BR (1) | BR9703773A (enExample) |
| CA (1) | CA2208939C (enExample) |
| DE (1) | DE69738462T2 (enExample) |
| ES (1) | ES2299182T3 (enExample) |
| IN (1) | IN192791B (enExample) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330389C (zh) * | 2003-03-05 | 2007-08-08 | 朱晓明 | 止血凝胶 |
| CN100384489C (zh) * | 2003-06-25 | 2008-04-30 | 伊西康公司 | 止血装置及其制造方法 |
| CN100398159C (zh) * | 2001-04-30 | 2008-07-02 | 北京纺织科学研究所 | 水溶性纤维素醚化衍生物止血材料 |
| CN100488490C (zh) * | 2000-04-28 | 2009-05-20 | 生物生命股份有限公司 | 应用血液凝固剂的止血剂、方法和载体 |
| CN101313915B (zh) * | 2007-05-30 | 2011-04-20 | 北京泰克美科技有限公司 | 透明质酸及其盐、交联透明质酸及其盐在制备治疗或预防海泡伤药物中的应用 |
| CN102350006A (zh) * | 2011-10-25 | 2012-02-15 | 中国纺织科学研究院 | 医用湿性复合敷料及其制造方法 |
| CN102912622A (zh) * | 2012-10-30 | 2013-02-06 | 威高集团有限公司 | 一种具有表层纳米结构的氧化再生纤维素类止血材料的制备方法 |
| CN103480033A (zh) * | 2013-10-08 | 2014-01-01 | 江苏昌吉永生物科技有限公司 | 一种医用生物多糖止血愈合海绵及其制备方法 |
| CN103603182A (zh) * | 2013-11-05 | 2014-02-26 | 王学洲 | 可溶性止血纱布及其制备方法 |
| CN105008611A (zh) * | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | 化学改性的纤维素纤维的处理 |
| CN111840633A (zh) * | 2019-04-29 | 2020-10-30 | 上海硅健生物材料有限公司 | 一种皮肤修复膜及其制备方法 |
| CN112107721A (zh) * | 2020-10-22 | 2020-12-22 | 伊索曼(中山)医疗器械有限公司 | 具有生物效应的合成敷料及其制备方法 |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2320502B (en) * | 1996-12-20 | 2000-09-20 | Johnson & Johnson Medical | Bioresorbable alginate derivatives |
| US6440940B1 (en) | 1997-12-18 | 2002-08-27 | Peter J. Doyle | Bioresorbable alginate derivatives |
| GB9810127D0 (en) | 1998-05-13 | 1998-07-08 | Ml Lab Plc | Prevention of surgical adhesions |
| NZ507832A (en) * | 1998-05-13 | 2003-03-28 | Ml Lab Plc | Dextrin-containing composition for preventing surgical adhesions |
| JP2004503483A (ja) * | 2000-06-09 | 2004-02-05 | ジェンザイム、コーポレーション | 低分子量ポリマー組成物 |
| JP4846147B2 (ja) * | 2001-12-17 | 2011-12-28 | 凸版印刷株式会社 | 酸化多糖類材料を被覆又は含浸させた材料の製造方法 |
| US7279177B2 (en) * | 2002-06-28 | 2007-10-09 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| US7252837B2 (en) | 2002-06-28 | 2007-08-07 | Ethicon, Inc. | Hemostatic wound dressing and method of making same |
| US7700500B2 (en) * | 2002-12-23 | 2010-04-20 | Kimberly-Clark Worldwide, Inc. | Durable hydrophilic treatment for a biodegradable polymeric substrate |
| WO2004080500A1 (en) * | 2003-03-10 | 2004-09-23 | Johnson & Johnson Medical Limited | Hydrocolloid materials for use in wound healing |
| US7019191B2 (en) | 2003-03-25 | 2006-03-28 | Ethicon, Inc. | Hemostatic wound dressings and methods of making same |
| DE10318802A1 (de) * | 2003-04-17 | 2004-11-04 | Aesculap Ag & Co. Kg | Selbsthaftendes resorbierbares Hämostyptikum |
| US20040241212A1 (en) * | 2003-05-30 | 2004-12-02 | Pendharkar Sanyog Manohar | Biodegradable hemostatic wound dressings |
| EP1742692A4 (en) * | 2004-03-17 | 2012-06-27 | Genzyme Corp | ANTI-ADHERENCE SPRAY |
| US7560076B2 (en) | 2004-08-18 | 2009-07-14 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| ES2537088T3 (es) | 2004-10-20 | 2015-06-02 | Ethicon, Inc. | Tejido multicapa absorbible reforzado para su uso en dispositivos médicos y método de fabricación |
| AU2005295365B2 (en) | 2004-10-20 | 2010-08-05 | Ethicon, Inc. | Absorbable hemostat |
| US9358318B2 (en) | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
| FR2898502B1 (fr) * | 2006-03-16 | 2012-06-15 | Sofradim Production | Tissu prothetique tridimensionnel a face dense resorbable |
| US8252333B2 (en) | 2006-01-26 | 2012-08-28 | Jorge Cueto-Garcia | Biodegradable, non-toxic biological adhesive for use in abdominal surgery |
| DE102006020498A1 (de) * | 2006-04-20 | 2007-10-25 | Aesculap Ag & Co. Kg | Schichtförmige Wundauflage |
| US8313762B2 (en) * | 2006-07-05 | 2012-11-20 | Medtronic Xomed, Inc. | Flexible bioresorbable hemostatic packing and stent |
| CN101121041A (zh) * | 2007-08-09 | 2008-02-13 | 美国淀粉医疗公司 | 变性淀粉可吸收性止血材料及其制备方法 |
| WO2009097343A1 (en) | 2008-01-28 | 2009-08-06 | Geno Llc | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
| US9376648B2 (en) | 2008-04-07 | 2016-06-28 | The Procter & Gamble Company | Foam manipulation compositions containing fine particles |
| CA2721938C (en) | 2008-04-24 | 2016-08-09 | Medtronic, Inc. | Chitosan-containing protective composition |
| CA2722155C (en) * | 2008-04-24 | 2019-07-30 | Medtronic, Inc. | Cold ionizing radiation sterilization |
| EP2291524A2 (en) | 2008-04-24 | 2011-03-09 | Medtronic, Inc | Rehydratable thiolated polysaccharide particles and sponge |
| CN102065849B (zh) | 2008-04-24 | 2015-04-29 | 麦德托尼克公司 | 基于壳聚糖和氧化多糖的保护性凝胶 |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| EP2362810A4 (en) | 2008-09-22 | 2013-09-11 | Geno Llc | CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITROGEN MONOXIDE (NO) |
| JP5024262B2 (ja) * | 2008-10-16 | 2012-09-12 | 凸版印刷株式会社 | 酸化多糖類材料を被覆又は含浸させた材料および生体適合材料 |
| JP5878866B2 (ja) | 2009-06-22 | 2016-03-08 | ゲノ エルエルシー | 一酸化窒素治療 |
| US8349354B2 (en) * | 2009-09-22 | 2013-01-08 | Ethicon, Inc. | Composite layered hemostasis device |
| DE102009053305A1 (de) | 2009-11-12 | 2011-08-18 | medichema GmbH, 09112 | Verfahren zur Herstellung einer schichtförmigen Wundauflage |
| KR101070358B1 (ko) | 2009-12-24 | 2011-10-05 | 한국생산기술연구원 | 의료용 부직포 및 그의 제조방법 |
| US8409526B2 (en) | 2010-12-09 | 2013-04-02 | General Electric Company | Cellulose substrates, compositions and methods for storage and analysis of biological materials |
| US9987115B2 (en) * | 2011-03-30 | 2018-06-05 | Boston Scientific Scimed, Inc. | Film encapsulated pelvic implant system and method |
| WO2016014158A1 (en) * | 2014-07-24 | 2016-01-28 | Arthrocare Corporation | Resilient polysaccharide foams and uses thereof |
| CN104689365A (zh) * | 2015-03-11 | 2015-06-10 | 中南大学 | 一种促创面愈合的复合生物敷料及其制备方法 |
| WO2022177891A1 (en) * | 2021-02-16 | 2022-08-25 | Cornell University | Polysaccharide-glycerol penetration-resistant compositions and surgical barriers made therefrom |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB779820A (en) * | 1954-04-05 | 1957-07-24 | Harry Pauling | Process for the production of cellulose or cellulose containing material having acid properties |
| US4543410A (en) * | 1982-06-21 | 1985-09-24 | Morca, Inc. | Absorbent cellulosic base structures |
| EP0303496A1 (en) * | 1987-08-12 | 1989-02-15 | Ethicon, Inc. | Resorbable surgical meshwork, prostheses of this meshwork and surgical uses thereof |
| US5180398A (en) * | 1990-12-20 | 1993-01-19 | Johnson & Johnson Medical, Inc. | Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide |
-
1997
- 1997-06-25 IN IN1209CA1997 patent/IN192791B/en unknown
- 1997-06-26 CA CA002208939A patent/CA2208939C/en not_active Expired - Lifetime
- 1997-06-26 AU AU27540/97A patent/AU725479B2/en not_active Expired
- 1997-06-27 DE DE69738462T patent/DE69738462T2/de not_active Expired - Lifetime
- 1997-06-27 JP JP9208254A patent/JPH1066723A/ja active Pending
- 1997-06-27 ES ES97304606T patent/ES2299182T3/es not_active Expired - Lifetime
- 1997-06-27 EP EP97304606A patent/EP0815879B1/en not_active Expired - Lifetime
- 1997-06-28 CN CN97117113.0A patent/CN1181980A/zh active Pending
- 1997-06-30 BR BR9703773A patent/BR9703773A/pt not_active Application Discontinuation
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100488490C (zh) * | 2000-04-28 | 2009-05-20 | 生物生命股份有限公司 | 应用血液凝固剂的止血剂、方法和载体 |
| CN100398159C (zh) * | 2001-04-30 | 2008-07-02 | 北京纺织科学研究所 | 水溶性纤维素醚化衍生物止血材料 |
| CN1330389C (zh) * | 2003-03-05 | 2007-08-08 | 朱晓明 | 止血凝胶 |
| CN100384489C (zh) * | 2003-06-25 | 2008-04-30 | 伊西康公司 | 止血装置及其制造方法 |
| US8709463B2 (en) | 2003-06-25 | 2014-04-29 | Ethicon, Inc. | Hemostatic devices and methods of making same |
| CN101313915B (zh) * | 2007-05-30 | 2011-04-20 | 北京泰克美科技有限公司 | 透明质酸及其盐、交联透明质酸及其盐在制备治疗或预防海泡伤药物中的应用 |
| CN102350006A (zh) * | 2011-10-25 | 2012-02-15 | 中国纺织科学研究院 | 医用湿性复合敷料及其制造方法 |
| CN102912622A (zh) * | 2012-10-30 | 2013-02-06 | 威高集团有限公司 | 一种具有表层纳米结构的氧化再生纤维素类止血材料的制备方法 |
| CN105008611A (zh) * | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | 化学改性的纤维素纤维的处理 |
| CN103480033B (zh) * | 2013-10-08 | 2015-10-28 | 江苏昌吉永生物科技有限公司 | 一种医用生物多糖止血愈合海绵及其制备方法 |
| CN103480033A (zh) * | 2013-10-08 | 2014-01-01 | 江苏昌吉永生物科技有限公司 | 一种医用生物多糖止血愈合海绵及其制备方法 |
| CN103603182A (zh) * | 2013-11-05 | 2014-02-26 | 王学洲 | 可溶性止血纱布及其制备方法 |
| CN103603182B (zh) * | 2013-11-05 | 2016-01-13 | 王学洲 | 可溶性止血纱布及其制备方法 |
| CN111840633A (zh) * | 2019-04-29 | 2020-10-30 | 上海硅健生物材料有限公司 | 一种皮肤修复膜及其制备方法 |
| CN111840633B (zh) * | 2019-04-29 | 2022-08-23 | 上海硅健生物材料有限公司 | 一种皮肤修复膜及其制备方法 |
| CN112107721A (zh) * | 2020-10-22 | 2020-12-22 | 伊索曼(中山)医疗器械有限公司 | 具有生物效应的合成敷料及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH1066723A (ja) | 1998-03-10 |
| ES2299182T3 (es) | 2008-05-16 |
| CA2208939C (en) | 2007-09-18 |
| AU2754097A (en) | 1998-01-22 |
| MX9704971A (es) | 1998-05-31 |
| CA2208939A1 (en) | 1997-12-28 |
| IN192791B (enExample) | 2004-05-22 |
| EP0815879B1 (en) | 2008-01-16 |
| DE69738462D1 (de) | 2008-03-06 |
| BR9703773A (pt) | 1998-11-10 |
| DE69738462T2 (de) | 2009-01-15 |
| EP0815879A2 (en) | 1998-01-07 |
| EP0815879A3 (en) | 1999-12-22 |
| AU725479B2 (en) | 2000-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1181980A (zh) | 来自氧化多糖类的可生物吸收的医用品 | |
| US20030073663A1 (en) | Bioabsorbable medical devices from oxidized polysaccharides | |
| CN1118301C (zh) | 防止手术后粘连的生物可消溶的氧化纤维素复合材料 | |
| Kronenthal | Biodegradable polymers in medicine and surgery | |
| US6630167B2 (en) | Hyaluronic acid anti-adhesion barrier | |
| US8877243B2 (en) | Cross-linked polysaccharide composition | |
| EP1794192B1 (en) | Photoreactive polysaccharide, photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom | |
| CN106674486A (zh) | 一种侧链含磷酰胆碱基团聚酯型聚氨酯材料及其制备方法 | |
| KR20230126734A (ko) | 의료 기기, 하이드로겔 및 그의 제조 방법과 응용 | |
| KR101180286B1 (ko) | 히알루론산 에폭사이드 유도체 하이드로겔을 포함하는 유착방지제 및 이의 제조 방법 | |
| JP6916353B1 (ja) | 癒着防止用高分子組成物 | |
| CN103495211B (zh) | 用于心脏手术的可吸收防粘连膜及其制备方法 | |
| EP2146755B1 (en) | Device made at least partially of n-acetylchitosan with controlled biodissolution | |
| CN113577400B (zh) | 一种海洋植物多糖防粘连材料的制备方法 | |
| Kronenthal | Ethicon, Inc., Somerville, New Jersey 08876 | |
| MXPA97004971A (en) | Biabsorbible medical devices from polyacaridos oxida | |
| JPWO2001034214A1 (ja) | 水難溶性化した可溶性セルロース誘導体の用途及びその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |